New Breast Cancer Test Equipment

A new device has been created in the United States to release women from the pain of a breast cancer test.

The device, called Computerized Ultrasound Risk Evaluation (CURE), is the result of research by experts at the Barbara Ann Karmanos Institute. CURE does not use radiation, and clinical trials have shown it can detect early breast cancer safely and accurately.

CURE uses multi-parameter ultrasound technology and computer algorithms instead of X-rays. Barbara Ann Karmanos, MD, associate professor of pediatrics, said CURE is less expensive than magnetic resonance imaging (MRI) technology and is particularly pain-free. The research team is looking for investment partners to put into commercial exploitation of their research.

CURE technology was announced just days after a US government team made recommendations against annual radiography for the majority of women in their 40s. The group also recommended women Breast cancer should only be started at age 50, and people 50 to 74 years should only be tested every two years instead of the current one. One of the reasons the group recommends is the high rate of errors in women under 50 years of age. This causes severe stress, leading to unnecessary biopsy and treatment tests. However, doctors and experts have opposed the above recommendation.